Guizhou Chanhen Chemical Corporation (SHE:002895)
China · Delayed Price · Currency is CNY 37.26
+1.15 (3.18%)
Apr 28, 2026, 3:04 PM CST
Guizhou Chanhen Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 7,727 | 5,531 | 3,968 | 3,084 | 2,130 |
Other Revenue | 600.83 | 374.72 | 351.03 | 363.11 | 399.94 |
| 8,328 | 5,906 | 4,320 | 3,447 | 2,530 | |
Revenue Growth (YoY) | 41.02% | 36.72% | 25.30% | 36.26% | 42.36% |
Cost of Revenue | 5,898 | 4,004 | 2,676 | 1,916 | 1,834 |
Gross Profit | 2,430 | 1,901 | 1,643 | 1,532 | 696.32 |
Selling, General & Admin | 362.91 | 326.87 | 300.82 | 264.68 | 142.65 |
Research & Development | 261.37 | 138.72 | 100.54 | 108.76 | 38.04 |
Other Operating Expenses | 160.56 | 127.91 | 113.78 | 91.2 | 51.58 |
Operating Expenses | 795.8 | 597.07 | 517.44 | 467.26 | 236.77 |
Operating Income | 1,634 | 1,304 | 1,126 | 1,065 | 459.55 |
Interest Expense | -74.93 | -135.21 | -155.54 | -125.76 | -43.59 |
Interest & Investment Income | 58.27 | 25.1 | 24.49 | 19.02 | 15.57 |
Currency Exchange Gain (Loss) | -4.79 | 13.22 | 2.42 | 26.25 | -6.85 |
Other Non Operating Income (Expenses) | -6.22 | -6.17 | -4.09 | -2.16 | -1.24 |
EBT Excluding Unusual Items | 1,606 | 1,201 | 992.94 | 982.03 | 423.44 |
Gain (Loss) on Sale of Investments | -29.75 | -9.81 | -21.3 | -28.11 | 6.69 |
Gain (Loss) on Sale of Assets | -1.2 | -3.87 | -0.4 | 1.19 | -3.91 |
Asset Writedown | -12.03 | -24.77 | -3.8 | -4.44 | -0.59 |
Other Unusual Items | 4.1 | 10.4 | -1.56 | -6.04 | 10.27 |
Pretax Income | 1,567 | 1,173 | 965.88 | 944.61 | 435.9 |
Income Tax Expense | 232.18 | 214.99 | 176.99 | 155.07 | 51.34 |
Earnings From Continuing Operations | 1,335 | 958.02 | 788.89 | 789.54 | 384.56 |
Minority Interest in Earnings | -75.02 | -1.54 | -22.49 | -30.88 | -16.8 |
Net Income | 1,260 | 956.48 | 766.4 | 758.66 | 367.76 |
Net Income to Common | 1,260 | 956.48 | 766.4 | 758.66 | 367.76 |
Net Income Growth | 31.76% | 24.80% | 1.02% | 106.29% | 157.88% |
Shares Outstanding (Basic) | 576 | 542 | 502 | 492 | 488 |
Shares Outstanding (Diluted) | 576 | 562 | 504 | 511 | 488 |
Shares Change (YoY) | 2.32% | 11.61% | -1.42% | 4.66% | 14.18% |
EPS (Basic) | 2.19 | 1.76 | 1.53 | 1.54 | 0.75 |
EPS (Diluted) | 2.19 | 1.70 | 1.52 | 1.48 | 0.75 |
EPS Growth | 28.77% | 11.82% | 2.47% | 97.10% | 125.86% |
Free Cash Flow | 272.15 | 407.34 | -275.31 | -1,261 | -1,837 |
Free Cash Flow Per Share | 0.47 | 0.72 | -0.55 | -2.47 | -3.76 |
Dividend Per Share | 1.800 | 1.200 | 1.000 | 0.700 | 0.200 |
Dividend Growth | 50.00% | 20.00% | 42.86% | 250.00% | - |
Gross Margin | 29.18% | 32.19% | 38.04% | 44.44% | 27.52% |
Operating Margin | 19.62% | 22.08% | 26.06% | 30.88% | 18.16% |
Profit Margin | 15.13% | 16.20% | 17.74% | 22.01% | 14.54% |
Free Cash Flow Margin | 3.27% | 6.90% | -6.37% | -36.58% | -72.62% |
EBITDA | 2,083 | 1,714 | 1,424 | 1,225 | 569.22 |
EBITDA Margin | 25.02% | 29.02% | 32.96% | 35.54% | 22.50% |
D&A For EBITDA | 449.43 | 409.7 | 298.03 | 160.63 | 109.67 |
EBIT | 1,634 | 1,304 | 1,126 | 1,065 | 459.55 |
EBIT Margin | 19.62% | 22.08% | 26.06% | 30.88% | 18.16% |
Effective Tax Rate | 14.81% | 18.33% | 18.32% | 16.42% | 11.78% |
Revenue as Reported | 8,328 | 5,906 | 4,320 | 3,447 | 2,530 |
Advertising Expenses | 2.49 | 4.72 | 1.5 | 1.49 | 1.77 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.